In Figure 3 of Section 4 “Designing the Drug Thalidomide”, two possible hydrolysis products are shown. Provide the mechanism to generate compound 4. The first step of the mechanism with the curved arrow pushing is done for you.
In Figure 3 of Section 4 “Designing the Drug Thalidomide”, two possible hydrolysis products are shown....
7. (4 pts.) In Figure 3 of Section 4 “Designing the Drug Thalidomide”, two possible hydrolysis products are shown. Provide the mechanism to generate compound 4. The first step of the mechanism with the curved arrow pushing is done for you. O + H-OH2 -N: Н. 0:0:- -NH2 N- 4 -ОН о о
Please write NEATLY and CLEARLY. (7.4 pts.) In Figure 3 of Section 4 “Designing the Drug Thalidomide”, two possible hydrolysis products are shown. Provide the mechanism to generate compound 4. The first step of the mechanism with the curved arrow pushing is done for you. + H-OH2 -N: :O: H -NH2 OH 0 SA H OH 5 -NH2 Figure 3: Possible biological degradtion products of thalidomide
Provide the mechanism to generate compound 4. The first step of the mechanism with the curved arrow pushing is done for you. -NH2 H O + H-OH2 4 -ОН 0:0:- H
Provide the mechanism to generate compound 4. The first step of the mechanism with the curved arrow pushing is done for you. -NH2 H O + H-OH2 4 -ОН 0:0:- H
8. (3 pts.) In the section “designing the drug thalidomide”, you learned that researchers create various analogs to determine which structural features are necessary for biological activity and which are responsible for side effects. the analogs were created using the molecule shown below. using the information found in table 3, draw the corresponding analogs #7, 8, and 11. 8. (3 pts.) In the section Designing the Drug Thalidomide" you learned that researchers create various analogs to determine which structural features...
8. In the section "Designing the Drug Thalidomide", you learned that researchers create various analogues to determine which structural features are necessary for biological activity and which are responsible for side effects. The analogues were created using the molecule shown below. Using the information found in Tabkw 3, sraw the corresponding analogs #7, 8, and 11. 9. Thalidomide is known to be an inhibitor of TBF-a. TNF-a is a protein mediator, and when to much of this mediator is present,...
2. (2.5 pts.) Shown below is the general mechanism for the interconversion of the enantiomers of thalidomide. Draw the appropriate curved arrow pushing for each step of the mechanism. H H 0 + H-OH2 + ÖH2 O :O: H Do H IM + OH2 O + H-OH2 O :O H Do O:O: H H H O + H-OH2 N O:O: H
Please write NEATLY and CLEARLY. Make arrows very obvious. 2. [2.5 pts.) Shown below is the general mechanism for the interconversion of the enantiomers of thalidomide. Draw the appropriate curved arrow pushing for each step of the mechanism. H-OH ÖH2 + H-SHz H N -0+ H-OH2 -N 0:0 H
please answer question 9 8 (3 pts.) In the section Designing the Drug Thalidomide", you learned that researchers create various analogs to determine which structural features are necessary for biological activity and which are responsible for side effects. The analogs were created using the molecule shown below. Using the information found in Table 3. draw the corresponding analogs #78, and 11 o N IHz NH2 IC 50.= 150 km Analog #7 "NH2 'NH2 OCHS KTOCH2CH3 "OCH₂ CH3 IC 5o =...
3. (a) (4 pts) Draw the thermodynamic and kinetic products of the hydrolysis of 3-bromo-3- methylbut-1-ene, and write a step-wise, arrow-pushing mechanism for the kinetic product. Br HO 3-bromo-3-methylbut-1-ene Thermodynamic Product Kinetic Product